Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Elizabeth Jaffee

GI Oncology · Johns Hopkins

View

Dr. Aparna Parikh

GI Oncology · PHS

View

Dr. Laura Vater

GI Oncology · IUSM

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    CWDr. Colin Weekes
    Leading Voice

    Dr. Colin Weekes

    Medical Oncology · Gastrointestinal Oncology
    Massachusetts General Hospital
    colin

    Research

    A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

    2025

    Via Clinical Cancer Research

    Research

    Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

    2025

    Via Nature Medicine

    Research

    Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer

    2025

    Via JCO Precision Oncology

    Research

    Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study

    2025

    Via The Oncologist

    Research

    Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

    2024

    Via Nature Medicine

    Research

    Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

    2024

    Via Clinical Cancer Research

    Research

    Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer

    2024

    Via The Lancet Oncology

    Research

    The Sequencing Conundrum in Localized Pancreatic Adenocarcinoma-Progress or Passive Acceptance?

    2024

    Via JAMA Oncology

    Research

    Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies

    2024

    Via Theranostics

    Research

    Establishing a Role for Local Therapy in Oligometastatic Pancreatic Cancer

    2024

    Via Journal of Clinical Oncology

    Research

    Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis

    2023

    Via Journal of the American College of Surgeons

    Research

    Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

    2023

    Via The Oncologist

    Research

    Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer

    2023

    Via Journal of Gastrointestinal Surgery

    Research

    Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma

    2023

    Via Annals of Surgery

    Research

    Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

    2023

    Via JAMA Network Open